Please login to the form below

Not currently logged in

New head for Deallus Consulting

Claudio D’Ambrosio is to take over as CEO at life sciences consultancy

Dr-Claudio-D Ambrosio Deallus-ConsultingThe life sciences consultancy Deallus Consulting has named Claudio D'Ambrosio as its new CEO, effective September 1, 2014.

D'Ambrosio joined Deallus in 2008 to lead its oncology practice. Since 2011, has served as head of North American operations for the consultancy.

He will succeed Richard Withers, the founder and current CEO, who will remain on the board of Deallus Holdings.

“We are extremely excited about Claudio's appointment. He brings a tremendous energy and a fresh approach to how we can achieve our vision and strategic imperatives and I have no doubt he is the right person to build on the success we have achieved under Richard's leadership,” said Hunt.

D'Ambrosio added that he was delighted to have the opportunity to lead Deallus through its next phase of growth.

“This is a really exciting time for the company as we continue on our growth trajectory and strive to cement our position as leaders in life science consulting,” he said.

“The core values that are embedded in the business and the immensely talented team that have grown and shaped the organisation give me a great sense of confidence about the future.”

Deallus was founded in the UK in 2004. Today the consultancy has close to 100 employees and offices in London, New York, New Jersey, Los Angeles and Singapore.

22nd July 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...